REVIEW
|
doi:10.20944/preprints202402.0963.v1
Subject:
Medicine And Pharmacology,
Neuroscience And Neurology
Keywords:
POMS; Pediatric Onset Multiple Sclerosis; Disease-modifying therapies; DMT; Pediatric MS; Interferons; Finglolimod; Teriflunomide; Cyclophosphamide; Rituximab; Ocrelizumab; Daclizumab; Alemtuzumab; Natalizumab; Ofatumumab; Siponimod; Vitamin D; TCR vaccine; Stem cell therapy; Glatiramer acetate; Azathioprine; Dimethyl fumarate; Mitoxantrone
Online: 19 February 2024 (14:52:05 CET)